Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, December 9 at 2:00 PM ET

Register Free →

This Solicitation opportunity from Oklahoma was posted on February 29, 2024. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Formulation, cGMP Manufacture and Stability Testing of SHetA2 (NSC 721689) Capsules

Closed
RFP-2024-112State & Local

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

AI Contract Overview

Show more

This contract involves the formulation, cGMP (current Good Manufacturing Practice) manufacturing, and stability testing of SHetA2 (NSC 721689) capsules to ensure they meet USP (United States Pharmacopeia) specifications and comply with FDA regulations. The project is initiated by the University of Oklahoma, a state-level organization, with the goal of producing high-quality capsules suitable for potential therapeutic or research applications. The solicitation, identified as RFP-2024-112, was posted on February 29, 2024, with a response deadline set for May 29, 2024. The work will be performed within Oklahoma, emphasizing adherence to strict manufacturing and testing standards to ensure product safety, efficacy, and regulatory compliance. Key points include the focus on formulation development, manufacturing under cGMP conditions, and conducting stability testing to verify the product's shelf life and quality over time. The contract aims to meet rigorous USP standards and FDA requirements, ensuring the capsules are suitable for clinical or commercial use. Interested vendors or organizations can find additional details and submit responses through the provided online portal, with Daisy Gulley serving as the primary contact for inquiries. The project underscores the university’s commitment to advancing pharmaceutical development and ensuring regulatory compliance for innovative drug formulations.

General Info

Place of Performance

OK, USA

Set-Aside

NONE

Documents

1
PDF, High priority: read this firstrfp
High

Read the document

Every page of every file, in your free workspace.

Read the document

AI Contract Breakdown

Uniform Contract Format

Contract not broken down yet

CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.

This one is closed. Find the next one like it.

Open contracts like this one, right now:

  • Sodium Chloride 0.9% Injection SupplierOpen now, due in 7 days
  • Supply of Surgical Detergent (Chlorhexidine Gluconate)Open now, due in 7 days
See open contracts like this

Ask CLEATUS

I've read this contract. Ask me anything.

Timeline

PhaseClosed
Posted

Solicitation

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyUniversity of Oklahoma
Contacts1 person available
OfficeN/A

Full Description

Show more
Formulation, cGMP Manufacture and Stability Testing of SHetA2 (NSC 721689) Capsules that Meet USP Specifications and FDA Regulations

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS